Impact of adjuvant therapy on outcomes of cancer of the stomach and gastroesophageal junction in the real-world
In the real-world setting, adjuvant chemotherapy proved to be a critical turning point of the FLOT regimen. It should be sought-even in a reduced form-in patients with TRG2/3.
Authors
- Florian Richter
- Christoph Röcken (ORCID: https://orcid.org/0000-0002-6989-8002)
- Anne Letsch
- Thomas Becker (ORCID: https://orcid.org/0000-0002-5193-4044)
- S. Heckl (ORCID: https://orcid.org/0000-0001-7002-1462)
- Dita Ulase (ORCID: https://orcid.org/0000-0002-8414-4399)
- Ulrike Ebert
- Hans‐Michael Behrens
Institutions
- Christian-Albrechts-Universität zu Kiel (DE)
- University Hospital Schleswig-Holstein (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- Gastric Cancer
- Published
- 2025-05-16
- DOI
- https://doi.org/10.1007/s10120-025-01624-8
- Citations
- 7
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 10.63